Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

SAMD14 Inhibitors

SAMD14 inhibitors represent a class of chemical compounds designed to selectively bind to and inhibit the activity of the SAMD14 protein. SAMD14, or Sterile Alpha Motif Domain-containing protein 14, is a member of the SAM domain-containing protein family, known for their role in protein-protein interactions. The SAM domain, which is a conserved structural motif, facilitates the oligomerization or interaction with other SAM-domain containing proteins, forming networks that participate in various cellular processes. SAMD14 inhibitors, through their modulation of SAMD14's interaction capabilities, affect intracellular signaling pathways, thereby potentially altering various cellular functions such as protein organization, assembly, or signaling transduction.

Chemically, SAMD14 inhibitors are often designed through structure-based drug design, utilizing the unique three-dimensional configuration of the SAM domain to create molecules that specifically fit into the binding site or allosterically modify the domain's functional configuration. These inhibitors can exhibit a variety of structural motifs that enable tight binding to the SAMD14 protein, preventing its native protein-protein interactions or altering its conformational stability. The specificity of these inhibitors is achieved through detailed analysis of SAMD14's active site or binding domain, ensuring minimal off-target effects in biochemical processes. In cellular biology, such inhibitors provide essential tools for dissecting the functional roles of SAMD14 in various signaling networks, helping to unravel its contributions to the regulation of cell growth, differentiation, or intracellular communication. The molecular design of these inhibitors often incorporates elements such as hydrophobic scaffolds, hydrogen-bond donors, and acceptors to fine-tune their affinity and selectivity toward SAMD14.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, possibly affecting the PI3K/AKT pathway and influencing protein interactions and function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor that can disrupt PI3K/AKT signaling, potentially altering protein regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR signaling, which can affect protein synthesis and potentially modulate protein function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK1/2, potentially affecting the MAPK/ERK pathway and thereby protein function and expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, which can influence stress response pathways and protein activity.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibits CaMKII, which can affect calcium signaling pathways and thereby influence protein function.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Disrupts calcium homeostasis by inhibiting the SERCA pump, which can affect protein regulation.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

Modulates calcium signaling by affecting IP3 receptors, potentially altering protein function.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can lead to increased protein levels by preventing protein degradation.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Inhibits calcineurin, which could affect NFAT signaling and protein interactions.